QA: Abbvie Inc in us_pharma/2023

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001551152_2024_Abbvie_Inc.pdf

Logs

Graph

Absolute values for 0001551152, Abbvie Inc

  xvar xval
0 AssetsCurrent 33,002,000,000
1 IntangibleAssetsNetIncludingGoodwill 87,903,000,000
2 PropertyPlantAndEquipmentNet 4,989,000,000
3 remainder_Assets 8,817,000,000
4 LiabilitiesCurrent 37,841,000,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 20,723,165,500
8 SellingGeneralAndAdministrativeExpense 12,514,831,916
9 ResearchAndDevelopmentExpense 8,130,622,924
10 remainder_Expenses 1,237,518,582
11 remainder_Revenues 52,678,462,564
12 remainder_NetIncome -6,465,396,771
13 remainder_ComprehensiveNetIncome 209,432,324
  yvar yval
0 Assets 134,711,000,000
1 Liabilities 37,841,000,000
2 Expenses 42,606,138,922
3 Revenues 52,678,462,564
4 StockholdersEquity 96,870,000,000
5 NetIncome 3,606,926,871
6 ComprehensiveNetIncome 3,711,643,033
7 BaseVar 137,255,715,290
8 EconomicCapitalRatiobeforeLimitedLiability 2.49
9 EconomicCapitalRatio 3.35

Edgar->Model Mapping

Feature Distribution

Change over Time